Plain-English translation of NCT06533423 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether a new self-management support program called NISMA helps patients who were recently diagnosed with inflammatory arthritis—such as rheumatoid arthritis, psoriatic arthritis, or axial spondyloarthritis—feel better and cope with their condition. The program teaches patients practical skills for managing their disease, dealing with pain and fatigue, and handling the emotional and social changes that come with a new diagnosis. Half of the participants will receive the NISMA program on top of their regular doctor visits, while the other half will receive standard care alone.
Many newly diagnosed arthritis patients struggle with ongoing pain, fatigue, medication side effects, and emotional distress, even when their disease is controlled with medication. This trial exists because research shows that teaching patients effective self-management strategies can improve their quality of life, but these skills are not routinely offered in most arthritis clinics.
You likely qualify if…
You likely don't qualify if…
If you join this study, you'll be randomly assigned to either receive the new NISMA self-management program (in addition to your regular rheumatology appointments) or to continue with standard care alone. The NISMA group will participate in structured sessions with healthcare professionals who will teach you practical strategies for managing your disease, coping with symptoms, and making lifestyle adjustments. All participants will continue seeing their rheumatologist and other team members as usual, and the study will track how you're doing over time.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
Denmark